欧洲带状疱疹疫苗接种的后勤和组织障碍:系统回顾

IF 2.7 Q3 IMMUNOLOGY
Michele Sorrentino , Alessandro Belpiede , Claudio Fiorilla , Michelangelo Mercogliano , Maria Triassi , Raffale Palladino
{"title":"欧洲带状疱疹疫苗接种的后勤和组织障碍:系统回顾","authors":"Michele Sorrentino ,&nbsp;Alessandro Belpiede ,&nbsp;Claudio Fiorilla ,&nbsp;Michelangelo Mercogliano ,&nbsp;Maria Triassi ,&nbsp;Raffale Palladino","doi":"10.1016/j.jvacx.2024.100544","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The Herpes Zoster (HZ) poses a significant public health threat, leading to morbidity and occasional mortality in unvaccinated adults aged 50 and older. With over 95 % of individuals in this age group globally having prior exposure to Varicella-Zoster Virus, a substantial portion of the world’s population is susceptible to developing HZ. Without vaccination, individuals reaching 85 years face a 50 % lifetime risk of HZ. Organizational and logistical barriers further hinder vaccination efforts, involving complexities in cost management, demanding vaccine storage requirements, supply limitations, distribution challenges, absence of a streamlined status collection system, and healthcare system deficiencies.</p></div><div><h3>Methods</h3><p>A systematic review was conducted on the studies that examined the logistical and organizational barriers to HZ vaccination among frail and older adults, aligning with the PRISMA guidelines. Eligibility criteria focus on English studies in Europe, excluding pediatric or irrelevant populations. Rayyan AI was used for data extraction, and bias was assessed using the AXIS tool.</p></div><div><h3>Results</h3><p>After excluding 841 based on titles and abstracts, 22 publications were selected. A thorough analysis identified 4 studies meeting inclusion criteria, conducted between 2009 and 2022, unveiling several barriers on HZ vaccination: challenges with healthcare professionals, obstacles related to patients’ perceptions and knowledge, difficulties in accessibility, structural issues, social dynamics.</p></div><div><h3>Conclusions</h3><p>The study represents a comprehensive examination, emphasizing the need for targeted interventions to overcome these barriers. The findings underscore the urgency of addressing these challenges to enhance vaccination rates and mitigate the public health burden associated with HZ.</p></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"20 ","pages":"Article 100544"},"PeriodicalIF":2.7000,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590136224001177/pdfft?md5=f4ee87863946d561157a0701ed2ab1b1&pid=1-s2.0-S2590136224001177-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review\",\"authors\":\"Michele Sorrentino ,&nbsp;Alessandro Belpiede ,&nbsp;Claudio Fiorilla ,&nbsp;Michelangelo Mercogliano ,&nbsp;Maria Triassi ,&nbsp;Raffale Palladino\",\"doi\":\"10.1016/j.jvacx.2024.100544\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>The Herpes Zoster (HZ) poses a significant public health threat, leading to morbidity and occasional mortality in unvaccinated adults aged 50 and older. With over 95 % of individuals in this age group globally having prior exposure to Varicella-Zoster Virus, a substantial portion of the world’s population is susceptible to developing HZ. Without vaccination, individuals reaching 85 years face a 50 % lifetime risk of HZ. Organizational and logistical barriers further hinder vaccination efforts, involving complexities in cost management, demanding vaccine storage requirements, supply limitations, distribution challenges, absence of a streamlined status collection system, and healthcare system deficiencies.</p></div><div><h3>Methods</h3><p>A systematic review was conducted on the studies that examined the logistical and organizational barriers to HZ vaccination among frail and older adults, aligning with the PRISMA guidelines. Eligibility criteria focus on English studies in Europe, excluding pediatric or irrelevant populations. Rayyan AI was used for data extraction, and bias was assessed using the AXIS tool.</p></div><div><h3>Results</h3><p>After excluding 841 based on titles and abstracts, 22 publications were selected. A thorough analysis identified 4 studies meeting inclusion criteria, conducted between 2009 and 2022, unveiling several barriers on HZ vaccination: challenges with healthcare professionals, obstacles related to patients’ perceptions and knowledge, difficulties in accessibility, structural issues, social dynamics.</p></div><div><h3>Conclusions</h3><p>The study represents a comprehensive examination, emphasizing the need for targeted interventions to overcome these barriers. The findings underscore the urgency of addressing these challenges to enhance vaccination rates and mitigate the public health burden associated with HZ.</p></div>\",\"PeriodicalId\":43021,\"journal\":{\"name\":\"Vaccine: X\",\"volume\":\"20 \",\"pages\":\"Article 100544\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590136224001177/pdfft?md5=f4ee87863946d561157a0701ed2ab1b1&pid=1-s2.0-S2590136224001177-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590136224001177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136224001177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景带状疱疹(HZ)对公共卫生构成了严重威胁,导致 50 岁及以上未接种疫苗的成年人发病,有时甚至死亡。全球该年龄组中 95% 以上的人曾接触过水痘-带状疱疹病毒,因此世界上有相当一部分人容易患上 HZ。如果不接种疫苗,年满 85 岁的人一生中患 HZ 的风险为 50%。组织和后勤方面的障碍进一步阻碍了疫苗接种工作,其中包括成本管理的复杂性、疫苗储存的苛刻要求、供应限制、配送挑战、缺乏简化的状态收集系统以及医疗保健系统的缺陷。资格标准侧重于欧洲的英文研究,排除了儿科或无关人群。使用 Rayyan AI 进行数据提取,并使用 AXIS 工具评估偏倚情况。结果根据标题和摘要排除了 841 篇研究后,选出了 22 篇出版物。通过全面分析,确定了 4 项符合纳入标准的研究,这些研究是在 2009 年至 2022 年期间进行的,揭示了接种 HZ 疫苗的几个障碍:与医护专业人员之间的挑战、与患者观念和知识相关的障碍、可及性方面的困难、结构性问题、社会动态。研究结果强调了应对这些挑战的紧迫性,以提高疫苗接种率并减轻与 HZ 相关的公共卫生负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review

Background

The Herpes Zoster (HZ) poses a significant public health threat, leading to morbidity and occasional mortality in unvaccinated adults aged 50 and older. With over 95 % of individuals in this age group globally having prior exposure to Varicella-Zoster Virus, a substantial portion of the world’s population is susceptible to developing HZ. Without vaccination, individuals reaching 85 years face a 50 % lifetime risk of HZ. Organizational and logistical barriers further hinder vaccination efforts, involving complexities in cost management, demanding vaccine storage requirements, supply limitations, distribution challenges, absence of a streamlined status collection system, and healthcare system deficiencies.

Methods

A systematic review was conducted on the studies that examined the logistical and organizational barriers to HZ vaccination among frail and older adults, aligning with the PRISMA guidelines. Eligibility criteria focus on English studies in Europe, excluding pediatric or irrelevant populations. Rayyan AI was used for data extraction, and bias was assessed using the AXIS tool.

Results

After excluding 841 based on titles and abstracts, 22 publications were selected. A thorough analysis identified 4 studies meeting inclusion criteria, conducted between 2009 and 2022, unveiling several barriers on HZ vaccination: challenges with healthcare professionals, obstacles related to patients’ perceptions and knowledge, difficulties in accessibility, structural issues, social dynamics.

Conclusions

The study represents a comprehensive examination, emphasizing the need for targeted interventions to overcome these barriers. The findings underscore the urgency of addressing these challenges to enhance vaccination rates and mitigate the public health burden associated with HZ.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine: X
Vaccine: X Multiple-
CiteScore
2.80
自引率
2.60%
发文量
102
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信